Zimmer Biomet Holdings, Inc. (ZBH)
USD 105.86
(-2.04%)
USD 105.86
(-2.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 21.49 Billion USD | 2.05% |
| 2022 | 21.06 Billion USD | -10.19% |
| 2021 | 23.45 Billion USD | -3.94% |
| 2020 | 24.41 Billion USD | -0.9% |
| 2019 | 24.63 Billion USD | 2.12% |
| 2018 | 24.12 Billion USD | -8.58% |
| 2017 | 26.39 Billion USD | -0.44% |
| 2016 | 26.5 Billion USD | -3.28% |
| 2015 | 27.4 Billion USD | 184.48% |
| 2014 | 9.63 Billion USD | 0.56% |
| 2013 | 9.58 Billion USD | 6.3% |
| 2012 | 9.01 Billion USD | 5.84% |
| 2011 | 8.51 Billion USD | 6.47% |
| 2010 | 7.99 Billion USD | 2.73% |
| 2009 | 7.78 Billion USD | 7.55% |
| 2008 | 7.23 Billion USD | 9.12% |
| 2007 | 6.63 Billion USD | 11.04% |
| 2006 | 5.97 Billion USD | 4.41% |
| 2005 | 5.72 Billion USD | 0.46% |
| 2004 | 5.69 Billion USD | 10.46% |
| 2003 | 5.15 Billion USD | 500.3% |
| 2002 | 858.9 Million USD | 15.29% |
| 2001 | 745 Million USD | 24.71% |
| 2000 | 597.4 Million USD | -1.42% |
| 1999 | 606 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 21.45 Billion USD | -0.21% |
| 2024 Q3 | 21.72 Billion USD | 0.93% |
| 2024 Q2 | 21.52 Billion USD | 0.32% |
| 2023 FY | 21.49 Billion USD | 2.05% |
| 2023 Q1 | 21.24 Billion USD | 0.84% |
| 2023 Q2 | 21.29 Billion USD | 0.24% |
| 2023 Q3 | 21.21 Billion USD | -0.36% |
| 2023 Q4 | 21.49 Billion USD | 1.32% |
| 2022 Q4 | 21.06 Billion USD | -1.25% |
| 2022 Q1 | 21.61 Billion USD | -7.84% |
| 2022 Q2 | 21.45 Billion USD | -0.76% |
| 2022 Q3 | 21.33 Billion USD | -0.56% |
| 2022 FY | 21.06 Billion USD | -10.19% |
| 2021 Q3 | 24 Billion USD | -0.89% |
| 2021 Q1 | 24.02 Billion USD | -1.6% |
| 2021 Q2 | 24.22 Billion USD | 0.82% |
| 2021 FY | 23.45 Billion USD | -3.94% |
| 2021 Q4 | 23.45 Billion USD | -2.3% |
| 2020 Q4 | 24.41 Billion USD | 1.63% |
| 2020 Q1 | 25.51 Billion USD | 3.55% |
| 2020 FY | 24.41 Billion USD | -0.9% |
| 2020 Q2 | 23.64 Billion USD | -7.31% |
| 2020 Q3 | 24.02 Billion USD | 1.6% |
| 2019 FY | 24.63 Billion USD | 2.12% |
| 2019 Q2 | 24.2 Billion USD | -0.34% |
| 2019 Q3 | 24.31 Billion USD | 0.45% |
| 2019 Q4 | 24.63 Billion USD | 1.33% |
| 2019 Q1 | 24.28 Billion USD | 0.67% |
| 2018 Q3 | 25.38 Billion USD | -0.43% |
| 2018 Q4 | 24.12 Billion USD | -4.95% |
| 2018 FY | 24.12 Billion USD | -8.58% |
| 2018 Q2 | 25.49 Billion USD | -6.22% |
| 2018 Q1 | 27.18 Billion USD | 2.99% |
| 2017 Q3 | 26.41 Billion USD | -0.29% |
| 2017 Q2 | 26.49 Billion USD | -1.83% |
| 2017 Q1 | 26.98 Billion USD | 1.81% |
| 2017 FY | 26.39 Billion USD | -0.44% |
| 2017 Q4 | 26.39 Billion USD | -0.09% |
| 2016 Q3 | 27.03 Billion USD | 3.81% |
| 2016 Q1 | 26.29 Billion USD | -3.39% |
| 2016 Q4 | 26.5 Billion USD | -1.95% |
| 2016 FY | 26.5 Billion USD | -3.28% |
| 2016 Q2 | 26.04 Billion USD | -0.97% |
| 2015 Q3 | 26.68 Billion USD | -1.89% |
| 2015 Q2 | 27.2 Billion USD | 58.25% |
| 2015 Q1 | 17.19 Billion USD | 78.42% |
| 2015 FY | 27.4 Billion USD | 184.48% |
| 2015 Q4 | 27.21 Billion USD | 1.99% |
| 2014 Q1 | 9.38 Billion USD | -2.09% |
| 2014 Q4 | 9.63 Billion USD | -0.37% |
| 2014 Q2 | 9.63 Billion USD | 2.75% |
| 2014 FY | 9.63 Billion USD | 0.56% |
| 2014 Q3 | 9.67 Billion USD | 0.34% |
| 2013 Q1 | 8.74 Billion USD | -2.97% |
| 2013 FY | 9.58 Billion USD | 6.3% |
| 2013 Q4 | 9.58 Billion USD | 2.39% |
| 2013 Q3 | 9.35 Billion USD | 2.86% |
| 2013 Q2 | 9.09 Billion USD | 4.03% |
| 2012 Q2 | 8.61 Billion USD | 0.15% |
| 2012 Q1 | 8.6 Billion USD | 1.04% |
| 2012 FY | 9.01 Billion USD | 5.84% |
| 2012 Q4 | 9.01 Billion USD | 2.6% |
| 2012 Q3 | 8.78 Billion USD | 1.95% |
| 2011 Q2 | 8.24 Billion USD | 1.62% |
| 2011 Q3 | 8.19 Billion USD | -0.61% |
| 2011 Q4 | 8.51 Billion USD | 3.86% |
| 2011 FY | 8.51 Billion USD | 6.47% |
| 2011 Q1 | 8.11 Billion USD | 1.47% |
| 2010 Q4 | 7.99 Billion USD | -0.05% |
| 2010 Q2 | 7.82 Billion USD | 0.07% |
| 2010 FY | 7.99 Billion USD | 2.73% |
| 2010 Q1 | 7.82 Billion USD | 0.47% |
| 2010 Q3 | 8 Billion USD | 2.25% |
| 2009 FY | 7.78 Billion USD | 7.55% |
| 2009 Q4 | 7.78 Billion USD | 1.8% |
| 2009 Q3 | 7.64 Billion USD | 2.49% |
| 2009 Q2 | 7.46 Billion USD | 3.18% |
| 2009 Q1 | 7.23 Billion USD | -0.1% |
| 2008 FY | 7.23 Billion USD | 9.12% |
| 2008 Q1 | 6.91 Billion USD | 4.3% |
| 2008 Q2 | 6.94 Billion USD | 0.34% |
| 2008 Q3 | 7.07 Billion USD | 1.96% |
| 2008 Q4 | 7.23 Billion USD | 2.26% |
| 2007 Q1 | 6.09 Billion USD | 2.07% |
| 2007 Q4 | 6.63 Billion USD | 4.19% |
| 2007 Q3 | 6.36 Billion USD | 0.73% |
| 2007 Q2 | 6.32 Billion USD | 3.66% |
| 2007 FY | 6.63 Billion USD | 11.04% |
| 2006 FY | 5.97 Billion USD | 4.41% |
| 2006 Q1 | 5.91 Billion USD | 3.41% |
| 2006 Q2 | 5.96 Billion USD | 0.78% |
| 2006 Q3 | 5.9 Billion USD | -0.92% |
| 2006 Q4 | 5.97 Billion USD | 1.12% |
| 2005 Q1 | 5.59 Billion USD | -1.83% |
| 2005 FY | 5.72 Billion USD | 0.46% |
| 2005 Q2 | 5.55 Billion USD | -0.71% |
| 2005 Q3 | 5.62 Billion USD | 1.26% |
| 2005 Q4 | 5.72 Billion USD | 1.78% |
| 2004 Q1 | 5.19 Billion USD | 0.66% |
| 2004 Q4 | 5.69 Billion USD | 6.92% |
| 2004 Q3 | 5.32 Billion USD | 0.37% |
| 2004 Q2 | 5.3 Billion USD | 2.26% |
| 2004 FY | 5.69 Billion USD | 10.46% |
| 2003 FY | 5.15 Billion USD | 500.3% |
| 2003 Q1 | 978.8 Million USD | 13.96% |
| 2003 Q2 | 1.14 Billion USD | 16.76% |
| 2003 Q3 | 1.24 Billion USD | 8.89% |
| 2003 Q4 | 5.15 Billion USD | 314.34% |
| 2002 Q3 | 863.4 Million USD | 0.97% |
| 2002 Q1 | 790.2 Million USD | 6.07% |
| 2002 Q2 | 855.1 Million USD | 8.21% |
| 2002 FY | 858.9 Million USD | 15.29% |
| 2002 Q4 | 858.9 Million USD | -0.52% |
| 2001 Q3 | 738.1 Million USD | 14.54% |
| 2001 Q2 | 644.4 Million USD | 4.1% |
| 2001 FY | 745 Million USD | 24.71% |
| 2001 Q1 | 619 Million USD | 3.69% |
| 2001 Q4 | 745 Million USD | 0.93% |
| 2000 Q4 | 597 Million USD | 0.0% |
| 2000 FY | 597.4 Million USD | -1.42% |
| 1999 FY | 606 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 70.638% |
| Allurion Technologies Inc. | 71.71 Million USD | -29876.712% |
| Artivion, Inc. | 792.39 Million USD | -2612.895% |
| Avanos Medical, Inc. | 1.69 Billion USD | -1170.202% |
| Butterfly Network, Inc. | 304.27 Million USD | -6964.981% |
| Butterfly Network, Inc. | 304.27 Million USD | -6964.981% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | -74.785% |
| Boston Scientific Corporation | 35.13 Billion USD | 38.818% |
| Perspective Therapeutics, Inc. | 58.09 Million USD | -36905.56% |
| CONMED Corporation | 2.3 Billion USD | -834.639% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | -129.589% |
| Paragon 28, Inc. | 340.69 Million USD | -6209.646% |
| Glaukos Corporation | 940.41 Million USD | -2185.897% |
| Globus Medical, Inc. | 5.08 Billion USD | -322.661% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -3076.204% |
| Integer Holdings Corporation | 2.94 Billion USD | -630.528% |
| Medtronic plc | 89.98 Billion USD | 76.11% |
| Nevro Corp. | 635.71 Million USD | -3281.542% |
| Owlet, Inc. | 44.12 Million USD | -48620.395% |
| Penumbra, Inc. | 1.55 Billion USD | -1281.278% |
| Vicarious Surgical Inc. | 119.86 Million USD | -17834.409% |
| Smith & Nephew plc | 9.98 Billion USD | -115.249% |
| Sonendo, Inc. | 78.16 Million USD | -27403.71% |
| STERIS plc | 11.06 Billion USD | -94.301% |
| Stryker Corporation | 39.91 Billion USD | 46.139% |
| Vapotherm, Inc. | 77.61 Million USD | -27596.123% |